Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 4/20 | 0.37 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | RARG | P13631 | 3/20 | 0.34 |
| ▸ | RARA | P10276 | 2/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.33 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14227671 | 0.90 | ALDH1A1 (0.38) | RARBMAPK1L3MBTL1 | |
| SCHEMBL17675719 | 0.87 | RXRA (0.43) | RARBRARGRARARXRACYP3A4 | |
| SCHEMBL17675717 | 0.86 | CYP3A4 (0.37) | RARBRARGRARARXRAMAPT | |
| SCHEMBL16624155 | 0.86 | ESR1 (0.40) | PPARGMAPK1CYP3A4HRH2HRH1 | |
| SCHEMBL14227659 | 0.85 | RARB (0.35) | RARBRARGRARARXRAMAPT | |
| SCHEMBL17676149 | 0.85 | RARB (0.33) | RARBRARGRARARXRA | |
| SCHEMBL16624154 | 0.84 | HRH3 (0.32) | HRH3GBA1 | |
| SCHEMBL14227676 | 0.81 | SLC6A4 (0.40) | RARBMAPTMAPK1CYP3A4L3MBTL1 | |
| SCHEMBL14227665 | 0.79 | MEN1 (0.40) | MAPK1 | |
| SCHEMBL17129734 | 0.79 | MAPT (0.34) | PPARGMAPTMAPK1CYP3A4HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160362356-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-15 | — | — | US | disclosed |
| US-20160362356-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-15 | — | — | US | disclosed |
| WO-2015144484-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362356-A1 | PHOTOLABILE PRO-FRAGRANCES | CUTA, FAAH, FAAH2 | RARB 2511/4885PPARG 1499/4885RARG 2385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.